The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Feb. 01, 2017
Applicants:

Japan As Represented BY Director-general of National Institute of Infectious Diseases, Tokyo, JP;

Denka Company Limited, Tokyo, JP;

National Center for Geriatrics and Gerontology, Obu, JP;

Inventors:

Kei Haga, Tokyo, JP;

Akira Fujimoto, Tokyo, JP;

Reiko Todaka, Tokyo, JP;

Kazuhiko Katayama, Tokyo, JP;

Akira Nakanishi, Obu, JP;

Motohiro Miki, Tokyo, JP;

Sakari Sekine, Tokyo, JP;

Hiroshi Otsuka, Tokyo, JP;

Shigetaka Mimori, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12Q 1/02 (2006.01); G01N 33/50 (2006.01); C12N 7/02 (2006.01); C07K 14/705 (2006.01); C07K 14/005 (2006.01); C12N 5/074 (2010.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/005 (2013.01); C07K 14/70503 (2013.01); C12N 5/0696 (2013.01); C12N 7/02 (2013.01); C12Q 1/02 (2013.01); G01N 33/50 (2013.01); G01N 33/5088 (2013.01); G01N 2333/08 (2013.01);
Abstract

An object of the present invention is to solve problems in terms of stagnation of research on norovirus by providing a cultured transgenic cell or a transgenic animal in which murine norovirus (MNV) can be grown across the barrier of host specificity in mammalian cells, and providing a screening method that uses the cultured transgenic cell or the transgenic animal. The present inventors have found that MNV infection is determined in a cultured transgenic mammalian cell or a mammal possessing the cultured transgenic mammalian cell as its own cell, the cultured transgenic mammalian cell containing one or more species selected from the entirety or a portion of the murine CD300F gene and/or a CD300 family gene having an extracellular domain nucleotide sequence similar to that of the murine CD300F gene. The present inventors have solved the aforementioned problems by providing, for example, a norovirus-related drug screening method on the basis of this finding.


Find Patent Forward Citations

Loading…